Mayo Clinic and Boston Scientific are joining forces over a new venture to accelerate the development of medical technology and new minimally invasive treatments for many health conditions that impede quality and longevity of life.
The accelerator, known as Motion Medical, will have its research facilities in One Discovery Square, the bioscience center in the Discovery Square research district. Both parties have committed millions of dollars over three years to develop and bring new solutions to the market to address unmet medical needs.
“Mayo Clinic is committed to accelerating the pace of discoveries to bring new technologies and treatments to patients faster,” Gianrico Farrugia, M.D., president and CEO of Mayo Clinic, said in a statement. “This collaboration and others like it will continue to strengthen Rochester and Minnesota as a biomedical innovation and economic powerhouse.”
This venture is another step forward in the collaboration between the two parties, combining Mayo Clinic’s clinical experience and patient care with Boston Scientific’s engineering, innovation and business expertise.
The accelerator, spreading over 1,800 square feet, will be a key tenant in One Discovery Square, developed by Mortenson. The building anchors the 16-block Discovery Square research district for the $5.6 billion Destination Medical Center economic development initiative in Rochester. The accelerator is expected to open in the fall.
Mayo Clinic and Boston Scientific have collaborated for nearly a decade to develop new devices and technologies in areas such as interventional cardiology, neuromodulation and urology. Together the companies have filed eight patent applications and collaborated on two first-in-human clinical trials.